News | April 27, 2022
Syngene full-year revenue from operations up 19% to Rs. 2604 crore
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
The company also plans to expand the facility
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
TCS provides clinical research services such as clinical data management, regulatory affairs, pharmacovigilance, risk-based monitoring, biostatistics and programming, medical writing, medical affairs and medico marketing, and health economics and outcomes research
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
The facility will be positioned as a Centre of Excellence for tertiary care services
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
Alkem’s domestic business grew 9.7 per cent versus the Indian pharmaceutical market growth of 8.5 per cent
Subscribe To Our Newsletter & Stay Updated
